| 000 | 01791 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250511140932.0 | ||
| 264 | 0 | _c19780218 | |
| 008 | 197802s 0 0 eng d | ||
| 022 | _a0031-7012 | ||
| 024 | 7 |
_a10.1159/000136727 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFregnan, G B | |
| 245 | 0 | 0 |
_aPharmacological profile of a new psychotherapeutic agent: 4-p-fluorophenyl-5-N(N'-o-methoxyphenyl)piperazinoethyl-4-oxazolin-2-one (LR 511). _h[electronic resource] |
| 260 |
_bPharmacology _c1977 |
||
| 300 |
_a485-502 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAggression _xdrug effects |
| 650 | 0 | 4 |
_aAnalgesics _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xpharmacology |
| 650 | 0 | 4 |
_aAntidepressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aAutonomic Nervous System _xdrug effects |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aCatalepsy _xdrug therapy |
| 650 | 0 | 4 |
_aConditioning, Psychological _xdrug effects |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aExploratory Behavior _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xpharmacology |
| 650 | 0 | 4 | _aLethal Dose 50 |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aOxazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xadministration & dosage |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aTranquilizing Agents _xpharmacology |
| 700 | 1 | _aVidali, M | |
| 773 | 0 |
_tPharmacology _gvol. 15 _gno. 6 _gp. 485-502 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000136727 _zAvailable from publisher's website |
| 999 |
_c583996 _d583996 |
||